Spin-off SironRX raises $3.4M to advance treatment of post-surgical wounds
This article was originally published in Clinica
Executive Summary
The Cleveland, Ohio-based company SironRX Therapeutics has just closed a $3.4m series A venture round, led by the Ohio-based North Coast Angel Fund. The company, a spin-off from Cleveland Clinic, is developing novel regenerative therapies to accelerate dermal and bone healing.